198 related articles for article (PubMed ID: 11782391)
21. Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry.
Obiezu CV; Soosaipillai A; Jung K; Stephan C; Scorilas A; Howarth DH; Diamandis EP
Clin Chem; 2002 Aug; 48(8):1232-40. PubMed ID: 12142379
[TBL] [Abstract][Full Text] [Related]
22. Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragments.
Väisänen V; Peltola MT; Lilja H; Nurmi M; Pettersson K
Anal Chem; 2006 Nov; 78(22):7809-15. PubMed ID: 17105175
[TBL] [Abstract][Full Text] [Related]
23. Human tissue kallikrein 9: production of recombinant proteins and specific antibodies.
Memari N; Grass L; Nakamura T; Karakucuk I; Diamandis EP
Biol Chem; 2006 Jun; 387(6):733-40. PubMed ID: 16800734
[TBL] [Abstract][Full Text] [Related]
24. Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma.
Borgoño CA; Fracchioli S; Yousef GM; Rigault de la Longrais IA; Luo LY; Soosaipillai A; Puopolo M; Grass L; Scorilas A; Diamandis EP; Katsaros D
Int J Cancer; 2003 Sep; 106(4):605-610. PubMed ID: 12845660
[TBL] [Abstract][Full Text] [Related]
25. Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines.
Paliouras M; Diamandis EP
Breast Cancer Res Treat; 2007 Mar; 102(1):7-18. PubMed ID: 16897430
[TBL] [Abstract][Full Text] [Related]
26. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer.
Tahir SA; Ren C; Timme TL; Gdor Y; Hoogeveen R; Morrisett JD; Frolov A; Ayala G; Wheeler TM; Thompson TC
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3653-9. PubMed ID: 14506154
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues.
Yousef GM; Scorilas A; Chang A; Rendl L; Diamandis M; Jung K; Diamandis EP
Prostate; 2002 May; 51(2):126-32. PubMed ID: 11948967
[TBL] [Abstract][Full Text] [Related]
28. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions.
Black MH; Magklara A; Obiezu C; Levesque MA; Sutherland DJ; Tindall DJ; Young CY; Sauter ER; Diamandis EP
Br J Cancer; 2000 Jan; 82(2):361-7. PubMed ID: 10646889
[TBL] [Abstract][Full Text] [Related]
29. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.
Luo LY; Katsaros D; Scorilas A; Fracchioli S; Bellino R; van Gramberen M; de Bruijn H; Henrik A; Stenman UH; Massobrio M; van der Zee AG; Vergote I; Diamandis EP
Cancer Res; 2003 Feb; 63(4):807-11. PubMed ID: 12591730
[TBL] [Abstract][Full Text] [Related]
30. Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids.
Obiezu CV; Shan SJ; Soosaipillai A; Luo LY; Grass L; Sotiropoulou G; Petraki CD; Papanastasiou PA; Levesque MA; Diamandis EP
Clin Chem; 2005 Aug; 51(8):1432-42. PubMed ID: 15961548
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
Yousef GM; Stephan C; Scorilas A; Ellatif MA; Jung K; Kristiansen G; Jung M; Polymeris ME; Diamandis EP
Prostate; 2003 Sep; 56(4):287-92. PubMed ID: 12858357
[TBL] [Abstract][Full Text] [Related]
32. Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serum.
Grauer LS; Finlay JA; Mikolajczyk SD; Pusateri KD; Wolfert RL
J Androl; 1998; 19(4):407-11. PubMed ID: 9733142
[TBL] [Abstract][Full Text] [Related]
33. Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females.
Al-Qahtani A; Muttukrishna S; Appasamy M; Johns J; Cranfield M; Visser JA; Themmen AP; Groome NP
Clin Endocrinol (Oxf); 2005 Sep; 63(3):267-73. PubMed ID: 16117813
[TBL] [Abstract][Full Text] [Related]
34. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
Mize GJ; Wang W; Takayama TK
Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
[TBL] [Abstract][Full Text] [Related]
35. Large-scale propagation of recombinant adherent cells that secrete a stable form of human glandular kallikrein, hK2.
Kumar A; Goel AS; Payne JK; Evans C; Mikolajczyk SD; Kuus-Reichel K; Saedi MS
Protein Expr Purif; 1999 Feb; 15(1):62-8. PubMed ID: 10024471
[TBL] [Abstract][Full Text] [Related]
36. Development of an immunofluorometric assay and quantification of human kallikrein 7 in tissue extracts and biological fluids.
Kishi T; Soosaipillai A; Grass L; Little SP; Johnstone EM; Diamandis EP
Clin Chem; 2004 Apr; 50(4):709-16. PubMed ID: 14764643
[TBL] [Abstract][Full Text] [Related]
37. Establishment of a serum tumor marker for preclinical trials of mouse prostate cancer models.
Huizen IV; Wu G; Moussa M; Chin JL; Fenster A; Lacefield JC; Sakai H; Greenberg NM; Xuan JW
Clin Cancer Res; 2005 Nov; 11(21):7911-9. PubMed ID: 16278416
[TBL] [Abstract][Full Text] [Related]
38. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
[TBL] [Abstract][Full Text] [Related]
39. Is human kallikrein-11 in gastric cancer treated with surgery and adjuvant chemoradiotherapy associated with survival?
Unal D; Tasdemir A; Oguz A; Eroglu C; Cihan YB; Turak EE; Karaman H; Soyuer S
Pathol Res Pract; 2013 Dec; 209(12):779-83. PubMed ID: 24169449
[TBL] [Abstract][Full Text] [Related]
40. Three new serum markers for prostate cancer detection within a percent free PSA-based artificial neural network.
Stephan C; Xu C; Brown DA; Breit SN; Michael A; Nakamura T; Diamandis EP; Meyer H; Cammann H; Jung K
Prostate; 2006 May; 66(6):651-9. PubMed ID: 16388506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
